These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

123 related articles for article (PubMed ID: 8828314)

  • 1. Use of Norplant in women with or at-risk for noninsulin-dependent diabetes.
    Womack J; Beal MW
    J Nurse Midwifery; 1996; 41(4):285-96. PubMed ID: 8828314
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Insulin sensitivity is unaltered by the use of the Norplant subdermal implant contraceptive.
    Koopersmith TB; Lobo RA
    Contraception; 1995 Mar; 51(3):197-200. PubMed ID: 7621688
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Oral contraceptives and coronary heart disease: modulation of glucose tolerance and plasma lipid risk factors by progestins.
    Crook D; Godsland IF; Wynn V
    Am J Obstet Gynecol; 1988 Jun; 158(6 Pt 2):1612-20. PubMed ID: 3287933
    [TBL] [Abstract][Full Text] [Related]  

  • 4. A comparison of the effects of NORPLANT capsules and NORPLANT-2 rods on clinical chemistry: metabolic changes.
    Singh K; Viegas OA; Ratnam SS
    Ann Acad Med Singap; 1990 Nov; 19(6):833-6. PubMed ID: 2130749
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Relationships between blood pressure, oral contraceptive use and metabolic risk markers for cardiovascular disease.
    Godsland IF; Crook D; Devenport M; Wynn V
    Contraception; 1995 Sep; 52(3):143-9. PubMed ID: 7587185
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The effects of different formulations of oral contraceptive agents on lipid and carbohydrate metabolism.
    Godsland IF; Crook D; Simpson R; Proudler T; Felton C; Lees B; Anyaoku V; Devenport M; Wynn V
    N Engl J Med; 1990 Nov; 323(20):1375-81. PubMed ID: 2146499
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Metabolic parameter, bleeding, and weight changes in U.S. women using progestin only contraceptives.
    Mainwaring R; Hales HA; Stevenson K; Hatasaka HH; Poulson AM; Jones KP; Peterson CM
    Contraception; 1995 Mar; 51(3):149-53. PubMed ID: 7621683
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Glucose and lipid metabolism with triphasic oral contraceptives in women with history of gestational diabetes.
    Kung AW; Ma JT; Wong VC; Li DF; Ng MM; Wang CC; Lam KS; Young RT; Ma HK
    Contraception; 1987 Mar; 35(3):257-69. PubMed ID: 3111786
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Effect of Norplant implants on liver, lipid and carbohydrate metabolism.
    Singh K; Viegas OA; Loke DF; Ratnam SS
    Contraception; 1992 Feb; 45(2):141-53. PubMed ID: 1559336
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Norplant-2 subdermal contraceptive system: experience in Taiwan.
    Lee TY; Yang YS; Tseng LH; Ko TM; Hsu MC; Chuang SM
    J Formos Med Assoc; 1993 May; 92(5):446-50. PubMed ID: 8104598
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Evaluation of a new triphasic oral contraceptive in private practice.
    Ellsworth HS; Ayerst RI; Harris JW; Stone RA; Anderson AE; Jones TL; Curtis MK
    Contraception; 1986 Nov; 34(5):435-42. PubMed ID: 3102161
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The effect of Norplant on glucose metabolism under hyperglycemic hyperinsulinemic conditions.
    Shamma FN; Rossi G; HajHassan L; Penzias AS; Connoly-Diamond M; Jones E; Diamond MP
    Fertil Steril; 1995 Apr; 63(4):767-72. PubMed ID: 7890060
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Immunolocalization of endothelin and neutral endopeptidase in the endometrium of users of subdermally implanted levonorgestrel (Norplant).
    Marsh MM; Butt AR; Riley SC; Rogers PA; Susil B; Affandi B; Findlay JK; Salamonsen LA
    Hum Reprod; 1995 Oct; 10(10):2584-9. PubMed ID: 8567775
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The effects of Implanon on lipid metabolism in comparison with Norplant.
    Suherman SK; Affandi B; Korver T
    Contraception; 1999 Nov; 60(5):281-7. PubMed ID: 10717780
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Carbohydrate metabolism before and after Norplant removal.
    Konje JC; Odukoya OA; Otolorin EO; Ewings PD; Ladipo OA
    Contraception; 1992 Jul; 46(1):61-9. PubMed ID: 1424624
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The performance of levonorgestrel rod and Norplant contraceptive implants: a 5 year randomized study.
    Sivin I; Campodonico I; Kiriwat O; Holma P; Diaz S; Wan L; Biswas A; Viegas O; el din Abdalla K; Anant MP; Pavez M; Stern J
    Hum Reprod; 1998 Dec; 13(12):3371-8. PubMed ID: 9886517
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Comparative metabolic effects of three types of combined oral contraceptive pills in Chinese women.
    Prasad RN; Liew D; Ratnam SS
    Contraception; 1989 Jan; 39(1):21-35. PubMed ID: 2521321
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Insulin resistance, secretion, and metabolism in users of oral contraceptives.
    Godsland IF; Walton C; Felton C; Proudler A; Patel A; Wynn V
    J Clin Endocrinol Metab; 1992 Jan; 74(1):64-70. PubMed ID: 1530790
    [TBL] [Abstract][Full Text] [Related]  

  • 19. A cross-over study of three oral contraceptives containing ethinyloestradiol and either desogestrel or levonorgestrel.
    Song S; Chen JK; Yang PJ; He ML; Li LM; Fan BC; Rekers H; Fotherby K
    Contraception; 1992 Jun; 45(6):523-32. PubMed ID: 1535580
    [TBL] [Abstract][Full Text] [Related]  

  • 20. A study on the effects of Norplant implantable contraceptive on lipid, lipoprotein, and apolipoprotein metabolism in Singaporean women.
    Singh K; Ratnam SS
    Contraception; 1997 Aug; 56(2):77-83. PubMed ID: 9315415
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.